skip to main content
Idioma:
Mostrar Somente
Refinado por: autor: Dalby, A remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Efficacy and Safety of Dapagliflozin in Type 2 Diabetes According to Baseline Blood Pressure Observations From DECLARE-TIMI 58 Trial
Efficacy and Safety of Dapagliflozin in Type 2 Diabetes According to Baseline Blood Pressure Observations From DECLARE-TIMI 58 Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and Safety of Dapagliflozin in Type 2 Diabetes According to Baseline Blood Pressure Observations From DECLARE-TIMI 58 Trial

Remo H. M. Furtado Itamar Raz; Erica L Goodrich; Sabina A Murphy; Deepak L Bhatt; Lawrence A Leiter; Darren K Mcguire; John P. H Wilding; Philip Aylward; Anthony J Dalby; Jose Carlos Nicolau

Circulation v. 145, n. 21, p. 1581-1591, 2022

Philadelphia 2022

Acesso online. A biblioteca também possui exemplares impressos.

2
Mortality and morbidity remain high despite captopril and/or valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction
Mortality and morbidity remain high despite captopril and/or valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction
Material Type:
Artigo 		Adicionar ao Meu Espaço

Mortality and morbidity remain high despite captopril and/or valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction

Harvey D. White Philip E. G Aylward; Zhen Huang; Anthony Dalby; Douglas Weaver; Stale Barvik; José Antônio Marin-Neto; Jan Murin; Rolf O Nordlander; Wiek H. van Gilst; Faiez Zannad; John J. V McMurray; Robert M Califf; Marc A Pfeffer

Circulation Baltimore v. 29, p. 3391-3399, 2005

Baltimore 2005

Localização: FMRP - Fac. Medicina de Ribeirão Preto    (pcd 1501773 )(Acessar)

3
Mortality and morbidity remain high despite captopril and/or valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction
Mortality and morbidity remain high despite captopril and/or valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction
Material Type:
Artigo 		Adicionar ao Meu Espaço

Mortality and morbidity remain high despite captopril and/or valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction

Harvey D. White Philip E. G Aylward; Zhen Huang; Anthony Dalby; Douglas Weaver; Stale Barvik; José Antônio Marin-Neto; Jan Murin; Rolf O Nordlander; Wiek H. van Gilst; Faiez Zannad; John J. V McMurray; Robert M Califf; Marc A Pfeffer

Circulation Baltimore v. 29, p. 3391-3399, 2005

Baltimore 2005

Localização: FMRP - Fac. Medicina de Ribeirão Preto    (pcd 1501773 )(Acessar)

4
Vorapaxar in the secondary prevention of atherothrombotic events
Vorapaxar in the secondary prevention of atherothrombotic events
Material Type:
Artigo 		Adicionar ao Meu Espaço

Vorapaxar in the secondary prevention of atherothrombotic events

David A Morrow Eugene Braunwald; Marc P Bonaca; Sebastian F Ameriso; Anthony J Dalby; Mary Polly Fish; Keith A. A Fox; Leslie J Lipka; Xuan Liu; Jose Carlos Nicolau; A. J. Oude Ophuis; Ernesto Paolasso; Benjamin M Scirica; Jindrich Spinar; Pierre Theroux; Stephen D Wiviott; John Strony; Sabina A Murphy; Jose Antonio Marin Neto; M Tonani; Jose Geraldo Speciali; Cristina Guandolini; TRA 2P–TIMI 50 Steering Committee and Investigators

The New England Journal of Medicine Boston v. 366, n. 15, p. 1404-1413, 2012

Boston 2012

Localização: FMRP - Fac. Medicina de Ribeirão Preto    (pcd 2400837 Estantes Deslizantes )(Acessar)

5
Vorapaxar in the secondary prevention of atherothrombotic events
Vorapaxar in the secondary prevention of atherothrombotic events
Material Type:
Artigo 		Adicionar ao Meu Espaço

Vorapaxar in the secondary prevention of atherothrombotic events

David A Morrow Eugene Braunwald; Marc P Bonaca; Sebastian F Ameriso; Anthony J Dalby; Mary Polly Fish; Keith A. A Fox; Leslie J Lipka; Xuan Liu; Jose Carlos Nicolau; A. J. Oude Ophuis; Ernesto Paolasso; Benjamin M Scirica; Jindrich Spinar; Pierre Theroux; Stephen D Wiviott; John Strony; Sabina A Murphy; Jose Antonio Marin Neto; M Tonani; Jose Geraldo Speciali; Cristina Guandolini; TRA 2P–TIMI 50 Steering Committee and Investigators

The New England Journal of Medicine Boston v. 366, n. 15, p. 1404-1413, 2012

Boston 2012

Localização: FMRP - Fac. Medicina de Ribeirão Preto    (pcd 2400837 Estantes Deslizantes )(Acessar)

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (1)

Data de Publicação 

De até
Refinar

Novas Pesquisas Sugeridas

Ignorar minha busca e procurar por tudo

Deste Autor:

  1. Dalby, A
  2. Marin-Neto, J
  3. Murphy, S
  4. Nicolau, J
  5. Aylward, P

Neste Assunto:

  1. Infarto Do Miocárdio
  2. Doenças Cardiovasculares
  3. Hemorragia
  4. Velhice
  5. Isquemia Cerebral

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.